A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia

• Christoph Schliemann,

  Affiliation Department of Medicine A, University Hospital Muenster, Muenster, Germany

  ⨯
• Joachim Gerss,

  Affiliation Institute of Biostatistics and Clinical Research, University Hospital Muenster, Muenster, Germany

  ⨯
• Stefanie Wiebe,

  Affiliation Department of Medicine A, University Hospital Muenster, Muenster, Germany

  ⨯
• Jan-Henrik Mikesch,

  Affiliation Department of Medicine A, University Hospital Muenster, Muenster, Germany

  ⨯
• Nicola Knoblauch,

  Affiliation Department of Medicine A, University Hospital Muenster, Muenster, Germany

  ⨯
• Tim Sauer,

  Affiliation Department of Medicine A, University Hospital Muenster, Muenster, Germany

  ⨯
• Linus Angenendt,

  Affiliation Department of Medicine A, University Hospital Muenster, Muenster, Germany

  ⨯
• Tobias Kewitz,

  Affiliation Centre for Clinical Trials, University Hospital Muenster, Muenster, Germany

  ⨯
• Marc Urban,

  Affiliation Centre for Clinical Trials, University Hospital Muenster, Muenster, Germany

  ⨯
• Trude Butterfass-Bahloul,

  Affiliation Centre for Clinical Trials, University Hospital Muenster, Muenster, Germany

  ⨯
• Sabine Edemir,

  Current address: Department of Medicine IV, University Hospital Halle, Halle (Saale), Germany

  Affiliation Department of Medicine A, University Hospital Muenster, Muenster, Germany

  ⨯
• Kerstin Vehring,

  Affiliation Department of Medicine A, University Hospital Muenster, Muenster, Germany

  ⨯
• Carsten Müller-Tidow,

  Current address: Department of Medicine IV, University Hospital Halle, Halle (Saale), Germany

  Affiliation Department of Medicine A, University Hospital Muenster, Muenster, Germany

  ⨯
• Wolfgang E. Berdel ,

  Contributed equally to this work with: Wolfgang E. Berdel, Utz Krug

  Affiliation Department of Medicine A, University Hospital Muenster, Muenster, Germany

  ⨯
• Utz Krug

  Contributed equally to this work with: Wolfgang E. Berdel, Utz Krug

  * E-mail: utz.krug@klinikum-lev.de

  Current address: Department of Medicine 3, Klinikum Leverkusen, Leverkusen, Germany

  Affiliation Department of Medicine A, University Hospital Muenster, Muenster, Germany

  ⨯